The first personal fine against a union official has been handed down in the wake of the High Court’s ruling that courts can order union officials to pay out of their own pockets for violating the Fair Work Act.
The Australian Competition and Consumer Commission is seeking special leave from the High Court to appeal a ruling in a case alleging drug giant Pfizer misused its market power ahead of the expiration of its patent for Lipitor.
The High Court has said pensions can count as lost earnings, agreeing with a ruling from the Full Court of the Supreme Court of South Australia that found an individual dying from work-related mesothelioma was owed compensation for the expected loss of his superannuation.
The government has won court approval to amend its defence mid-trial in a class action brought by businesses alleging they were harmed when the Rudd Government cancelled a program that subsidised home insulation installations during the economic downturn.
Apple has reached an in-principle settlement with the consumer watchdog in an enforcement action over the tech giant’s repair policies, a judge was told Tuesday.
The litigation funder underwriting a class action over the collapse of Banksia Securities lost its bid Thursday to block a group member from challenging a $64 million settlement in the case.
Law firm Corrs Chambers Westgarth is following in the footsteps of Squire Patton Boggs, with both now challenging a ruling that halted their shareholder class actions against logistics startup GetSwift.
Luxury home builder Glenville has won an appeal of a ruling that shielded certain documents from production by legal professional privilege in a lawsuit against global packaging giant Amcor over liability for asbestos remediation at a former Amcor paper mill site in a Melbourne suburb.
In a major loss for the ACCC, the Full Federal Court on Friday tossed the competition regulator’s challenge to a ruling that drug giant Pfizer did not misuse its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.
A judge overseeing a trial against S&P Global over its ratings of synthetic collateralised debt obligations has tossed the company’s damages expert, saying she lacked sufficient expertise to provide an opinion on the value of the instruments.